We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Puerto Rico Plant Warned for Skipping Specification Testing
Mylan Puerto Rico Plant Warned for Skipping Specification Testing
December 6, 2011
The FDA has warned Mylan’s Caguas, Puerto Rico, facility for current good manufacturing practice (cGMP) violations, including a lack of specification testing, for finished drug products.